- Filed
- Jun 16, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2020 · Jun 9, 2022 | 165.19M sh |
| Cash And Equivalents | Q2 2020 · Jun 30, 2020 | $1.89K |
| Cash And Equivalents | Q2 2020 · Dec 31, 2019 | $9.33K |
| Current Liabilities | Q2 2020 · Jun 30, 2020 | $308.04K |
| Current Liabilities | Q2 2020 · Dec 31, 2019 | $221.64K |
| Total Liabilities | Q2 2020 · Jun 30, 2020 | $868.82K |
| Total Liabilities | Q2 2020 · Dec 31, 2019 | $747.46K |
| Current Assets | Q2 2020 · Jun 30, 2020 | $160.9K |
| Current Assets | Q2 2020 · Dec 31, 2019 | $70.76K |
| Total Assets | Q2 2020 · Jun 30, 2020 | $160.9K |
| Total Assets | Q2 2020 · Dec 31, 2019 | $70.76K |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 165.19M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 165.19M sh |
| Operating Cash Flow restated | Q2 2020 · Jun 30, 2019 | $28.44K |
| Stockholders Equity | Q2 2020 · Jun 30, 2019 | −$620.33K |
| Stockholders Equity | Q2 2020 · Mar 31, 2019 | −$713.85K |
| Stockholders Equity | Q2 2020 · Dec 31, 2018 | −$670.89K |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | $0.00 |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | $0.00 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | $0.00 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | $0.00 |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $125.73K |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $291.46K |
| Net Income | Q2 2020 · Jun 30, 2019 | $93.52K |
| Net Income | Q2 2020 · Jun 30, 2019 | $50.56K |
| Net Income | Q2 2020 · Mar 31, 2019 | −$42.96K |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | $57.82K |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | −$25.61K |
| Revenue | Q2 2020 · Jun 30, 2019 | $183.55K |
| Revenue | Q2 2020 · Jun 30, 2019 | $265.85K |